Problem statement: Answer the multiple-choice question.
Question: Which drug has a 10.541\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a.) Cc1cc(OC(=O)c2ccc(C)c(C)c2)c([N+](=O)[O-])c(=O)[nH]1
b.) CCc1nnc(NC(=O)c2n[nH]c(=O)c3ccccc23)s1
c.) COc1ccc(C(CC(=O)O)NC(=O)C2CCCCC2)cc1
d.) O=S(=O)(c1ccccc1)N1CCN(C(=S)NCc2ccccc2)CC1
e.) CCCCN(C(=O)c1ccc(C#N)cc1)c1c(N)n(CCC)c(=O)[nH]c1=O
Answer: e. CCCCN(C(=O)c1ccc(C#N)cc1)c1c(N)n(CCC)c(=O)[nH]c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCN(C(=O)c1ccc(C#N)cc1)c1c(N)n(CCC)c(=O)[nH]c1=O
CCCCN(C(=O)c1ccc(C#N)cc1)c1c(N)n(CCC)c(=O)[nH]c1=O
N-(6-amino-2,4-dioxo-1-propylpyrimidin-5-yl)-N-butyl-4-cyanobenzamide